InvestorsHub Logo
icon url

sab63090

08/17/20 8:09 AM

#32928 RE: Fosco1 #32926

@Fosco

Thanks for your reply to GD and I don't know who Soxrates is or even where he posts, basically I favor your clear cut views, but I am now not clear where you stand on whether (or not) $CVM offers very good or very minimal improvement over Standard of Care.

I do think $CVM would be a great "pre-treatment" for Optivo or Keytruda as an improvement to their success.